Catalyst Crew Technologies Corp. (OTC: CCTC) announced today that it has submitted a corporate action request to the Financial Industry Regulatory Authority (FINRA) seeking approval to change its corporate name to LataMed AI Corp. and its trading symbol to reflect the company's new strategic direction. The proposed changes, which were approved by the company's Board of Directors and majority shareholder, are designed to better align the company's public identity with its transition toward artificial intelligence-enabled healthcare technology, with an initial focus on Latin America.
The company emphasized that the name and symbol change does not involve any reverse stock split, forward stock split, recapitalization, or change to its capital structure. The issued and outstanding share count will remain unchanged, and shareholders do not need to take any action. Upon FINRA approval, Catalyst Crew Technologies plans to file a Certificate of Amendment with the Nevada Secretary of State to effect the change, which would become effective after required filings and publication by FINRA on the Daily List.
Dr. Kevin Rodan Levy, Chief Executive Officer of Catalyst Crew Technologies, stated, "There is no change to the Company’s capital structure as part of this process. This proposed name change is intended to better align the Company’s public identity with its healthcare technology strategy and long-term market focus." The company is actively executing its strategic transition into AI-enabled healthcare, pursuing opportunities in telehealth infrastructure, remote patient monitoring, healthcare data analytics, and integrated digital care platforms. These initiatives aim to improve access, efficiency, and care coordination in emerging markets, with an initial emphasis on Latin America.
Catalyst Crew Technologies Corp. is an artificial intelligence-driven healthcare technology company focused on developing scalable digital health solutions for emerging markets. The company has not yet generated revenues from its newly announced business direction and faces risks associated with implementing its business plan, securing financing, completing acquisitions, and obtaining regulatory approvals. No assurance can be given that FINRA will approve the proposed name change or the requested new trading symbol, or the timing of any such approval.
For more information, visit https://catalystcrewai.com or review the company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
